Diagnostic algorithm for papillary urothelial tumors in the urinary bladder |
| |
Authors: | Jung-Weon Shim Kang Su Cho Young-Deuk Choi Yong-Wook Park Dong-Wha Lee Woon-Sup Han Sang-In Shim Hyun-Jung Kim Nam Hoon Cho |
| |
Affiliation: | (1) Department of Pathology, Hangang Sacred Heart Hospital, Seoul, South Korea;(2) Department of Urologic Oncology, Yonsei University College of Medicine, Seoul, South Korea;(3) Department of Pathology, Hanyang University Guri Hospital, Seoul, South Korea;(4) Department of Pathology, Soonchunhyang University Hospital, Seoul, South Korea;(5) Department of Pathology, Ewha Womans University Mokdong Hospital, Seoul, South Korea;(6) Department of Pathology, Catholic University of Korea St. Mary’s Hospital, Seoul, South Korea;(7) Department of Pathology, Inje University Sanggye Paik Hospital, Seoul, South Korea;(8) Korean Urologic Pathology Society, Seoul, South Korea;(9) Department of Pathology, Yonsei University College of Medicine, Seodaemoon-ku Sinchon-dong 134, Seoul, 120-752, South Korea |
| |
Abstract: | Papillary urothelial neoplasms with deceptively bland cytology cannot be easily classified. We aimed to design a new algorithm that could differentiate between these neoplasms based on a scoring system. We proposed a new scoring system that enables to reproducibly diagnose non-invasive papillary urothelial tumors. In this system, each lesion was given individual scores from 0 to 3 for mitosis and cellular thickness, from 0 to 2 for cellular atypia, and an additional score for papillary fusion. These scores were combined to form a summed score allowing the tumors to be ranked as follows: 0–1 = UP, 2–4 = low malignant potential (LMP), 5–7 = low-grade transitional cell carcinoma (TCC), and 8–9 = high-grade TCC. In addition to the scoring system, ancillary studies of MIB and p53 indexes with CK20 expression pattern analyses were compared together with clinical parameters. The MIB index was strongly correlated with disease progression. Four of the 22 LMP patients (18.2%) had late recurrences, two of these four (9.1%) had progression to low-grade carcinoma. The MIB index for LMP patients was strongly associated with recurrence (recurrence vs. non-recurrence, 16.5 vs. 8.1, p < 0.001). The proposed scoring system could enhance the reproducibility to distinguish papillary urothelial neoplasms. |
| |
Keywords: | Papillary urothelial neoplasm of low malignant potential Recurrence MIB |
本文献已被 PubMed SpringerLink 等数据库收录! |
|